Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Matthew T. Duvernay, Michael Benatar et al.|The Lancet Neurology|2023Cited by 255
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, G. Garcia Gutierrez, Jeffrey Statland et al.|Neurology|2020Cited by 201
Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight HeparinMehmet Kurtoğlu, Volkan Granit, Hakan Yanar et al.|World Journal of Surgery|2004Cited by 149
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseasesMichael Benatar, Joanne Wuu, Caroline McHutchison et al.|Brain|2021Cited by 116
An International Perspective on Preceding Infections in Guillain-Barré SyndromeSonja E. Leonhard, Soledad Monges, Annemiek A. van der Eijk et al.|Neurology|2022Cited by 85